Open Access

Expression of BMP‑4 and Smad1 in patients with Hirschsprung disease and its clinical significance

  • Authors:
    • Jianjun Zhang
    • Fengli Liu
  • View Affiliations

  • Published online on: April 25, 2019     https://doi.org/10.3892/etm.2019.7530
  • Pages: 225-229
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Expression and clinical significance of bone morphogenetic protein (BMP)‑4 and Smad1 in patients with Hirschsprung disease (HD) were investigated. A retrospective analysis of 96 HD patients (experimental group) admitted to Xuzhou Children's Hospital, Xuzhou Medical University from June 2015 to June 2017 was performed. According to the samples, the experimental group was divided into the stenosis group, the transition group and the expansion group. Forty‑seven children with colostomy due to intestinal obstruction were selected as the control group. The expression levels of BMP‑4 and Smad1 proteins were detected by immunohistochemical staining. The expression levels of BMP‑4 and Smad mRNA were detected by real‑time quantitative PCR (RT‑qPCR), and were quantified and compared. Via immunohistochemistry, BMP‑4 and Smad1 proteins were detected in the samples of different parts of HD patients and children with intestinal obstruction. The positive expression levels of BMP-4 and Smad1 proteins in the transition group were decreased compared with those in the expansion and control groups (P<0.05), and the positive expression levels of BMP-4 and Smad1 proteins in the stenosis group were decreased compared with those in the transition, expansion, and control groups (P<0.05). Also, the gene expression levels of BMP‑4 and Smad1 in the transition and stenosis groups were successively decreased, and the differences were statistically significant (P<0.05). In conclusion, the expression of BMP‑4 and Smad1 in the intestinal plexus of HD lesions was significantly reduced, indicating that BMP‑4 and Smad1 are closely related to the occurrence of HD, and it is suspected that they have a certain influence on the intestinal development of congenital digestive tract malformations.
View Figures
View References

Related Articles

Journal Cover

July-2019
Volume 18 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J and Zhang J: Expression of BMP‑4 and Smad1 in patients with Hirschsprung disease and its clinical significance. Exp Ther Med 18: 225-229, 2019
APA
Zhang, J., & Zhang, J. (2019). Expression of BMP‑4 and Smad1 in patients with Hirschsprung disease and its clinical significance. Experimental and Therapeutic Medicine, 18, 225-229. https://doi.org/10.3892/etm.2019.7530
MLA
Zhang, J., Liu, F."Expression of BMP‑4 and Smad1 in patients with Hirschsprung disease and its clinical significance". Experimental and Therapeutic Medicine 18.1 (2019): 225-229.
Chicago
Zhang, J., Liu, F."Expression of BMP‑4 and Smad1 in patients with Hirschsprung disease and its clinical significance". Experimental and Therapeutic Medicine 18, no. 1 (2019): 225-229. https://doi.org/10.3892/etm.2019.7530